ľֱ Launches Giving Tuesday Campaign to Support Free Healthcare Services for the Local Community
The annual season of giving reveals the transformational powers of empathy and solidarity. In the…
News Archive
Now Viewing
All News
FDA Awards Orphan Drug Designation for Brain Cancer Drug Development by Helix 51 Company
U.P. Oncolytics, a company in ľֱ’s Helix 51 biomedical incubator, has…
ľֱ College of Nursing Programs Awarded National Accreditation
Two ľֱ nursing programs have earned full accreditation by the Commission…
Dr. Erin Howe Awarded Research Grant to Study Molecular Mechanisms Driving Metastatic Breast Cancer
ľֱ cancer biologist Erin Howe, PhD, has been awarded a $100,000 grant…
PT Solutions and ľֱ Partner to Address Physical Therapy Workforce Shortage and Access to Healthcare Education
A new partnership between ľֱ (RFU) and PT Solutions Physical Therapy (PTS)…
NIH Fast-Track Grant for Novel Therapeutic to Treat Glioblastoma Awarded to ľֱ Helix 51 Incubator Company
U.P. Oncolytics, a company in ľֱ’s Helix 51 biomedical incubator, has…
NIH Awards $9.8 million in Funding to ľֱ Researchers for Projects Related to Brain Function and Diseases, Cancer and Parasitic Infections
Three ľֱ scientists have been awarded approximately $9.8 million in funding…
New Directions: Center for Genetic Diseases
The new director of the Center for Genetic Diseases, molecular biologist Weihang “Valerie” Chai, PhD, wants to establish…
Grainger Support Primes Startups for Success
From nurturing companies in a world-class research environment to providing hands-on experiences for students, the Helix…
Reflecting on a Legacy of Discovery
ľֱ of Medicine and Science became the first medical institution in the United States to recognize…